The Office for Life Sciences of the government of the United Kingdom has designated six new locations in the country as ‘Life Sciences Opportunity Zones’, of which the Harwell Science and Innovation Campus is one.
The Office for Life Sciences of the government of the United Kingdom has designated six new locations in the country as ‘Life Sciences Opportunity Zones’, of which the Harwell Science and Innovation Campus is one.
In a Feb. 20, 2020 press release, Harwell revealed that this designation is one of only seven across the whole country and the only one in Oxfordshire/Thames Valley area. The designations are valid for a period of 10 years and will see the UK government working with Harwell to attract both inward and foreign investment, establish trade agreements, and promote the campus as a world-leading location for companies to establish themselves.
“The life sciences industry contributes over £70 billion [US $90.4 billion] per annum to the UK economy and provides 240,000 jobs. Harwell Campus plays an increasingly important role at the center of this sector,” said Gordon Duncan, partner, Harwell Science and Innovation Campus, in the press release. “We have a unique platform here to help accelerate research and innovation around the country, taking applied research and turning it into commercial outputs using state-of-the-art technologies and applications-this is unparalleled across Europe.”
Source: Harwell
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.